Top Executives Make Strategic Moves With Vicarious Surgical Stock!

TipRanksFeb 21 21:07 ET

Insider Sale: CEO of $RBOT Sells 943 Shares

Quiver QuantitativeFeb 21 13:30 ET

Goldman Sachs Siasun Robot&Automation deep research (3): Humanoid robots may be nearing mass production, with turning points emerging in three areas.

Humanoid robots are rapidly developing, but overall technology has not yet met the requirements for large-scale application in the industrial or Consumer sectors. Goldman Sachs believes that the turning point for humanoid robot technology may occur in three areas: solving multiple general tasks, high success rates and sustained robustness, and rapid reasoning. Currently, the development of humanoid robots still faces some obstacles, such as the lack of original data needed for training.

wallstreetcnFeb 20 22:32 ET

Vicarious Surgical: Mazzola Will Be COO Until Effective Date, Responsibilities to Be Transitioned to Randy Clark, Co Pres >RBOT

Dow JonesFeb 18 16:11 ET

Vicarious Surgical Announces Planned Retirement of Chief Operating Officer

BusinesswireFeb 18 16:05 ET

Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

Analysts NotebookFeb 13 06:50 ET